Literature DB >> 6280889

An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice.

A Matsumori, C Kawai.   

Abstract

Severe myocarditis was induced in inbred BALB/c mice inoculated with the M variant of encephalomyocarditis (EMC) virus. The mortality rate was maximal on the fourth day, then decreased gradually, but increased again between the eleventh and fourteenth days. Gross myocardial lesions were seen on the surface of the ventricles in 62 of 125 mice (49.6%) after the fifth day. These myocardial lesions were observed more frequently in the dead mice (46 of 49, 93.9%). Cavity dimensions and wall thickness were measured in two groups of mice with myocarditis. On days 5-7, the cavity dimensions of the right (RV) and left (LV) ventricles in inoculated mice (0.92 +/- 0.51 mm and 1.21 +/- 0.18 mm, respectively) were significantly larger than those in controls (RV 0.54 +/- 0.17, LV 1.01 +/- 0.15; p less than 0.05). The wall thickness of the RV (0.46 +/- 0.09, controls 0.64 +/- 0.11; p less than 0.001) and the LV (0.97 +/- 0.13, controls 1.12 +/- 0.19; p less than 0.05) was significantly decreased. On days 8-14, dilatation of the LV was more pronounced (1.48 +/- 0.37, p less than 0.005) than during days 5-7, and the interventricular septum was also thinner. Pleural effusion, ascites and congestion of the lungs and liver were noted, and death seemed due to congestive heart failure. This study is the first documentation of congestive heart failure after viral infection is an experimental animal.

Entities:  

Mesh:

Year:  1982        PMID: 6280889     DOI: 10.1161/01.cir.65.6.1230

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  22 in total

1.  Myocarditis: some current perspectives and future directions.

Authors:  H A McAllister
Journal:  Tex Heart Inst J       Date:  1987-12

Review 2.  Immunomodulating therapy in experimental myocarditis.

Authors:  A Matsumori; C Kawai
Journal:  Springer Semin Immunopathol       Date:  1989

3.  Cardiac gene expression and systemic cytokine profile are complementary in a murine model of post-ischemic heart failure.

Authors:  S Lachtermacher; B L B Esporcatte; F Montalvão; P C Costa; D C Rodrigues; L Belem; A Rabischoffisky; H C C Faria Neto; R Vasconcellos; S Iacobas; D A Iacobas; H F R Dohmann; D C Spray; R C S Goldenberg; A C Campos-de-Carvalho
Journal:  Braz J Med Biol Res       Date:  2010-03-06       Impact factor: 2.590

4.  Natural history of left ventricular function in neonatal Coxsackie myocarditis.

Authors:  A Rozkovec; G Cambridge; M King; K A Hallidie-Smith
Journal:  Pediatr Cardiol       Date:  1985       Impact factor: 1.655

5.  Role of substance P in viral myocarditis in mice.

Authors:  Yong Wang; Miho Shimada; Yawei Xu; Dayi Hu; Ryosuke Nishio; Akira Matsumori
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

Review 6.  Rodent models of heart failure: an updated review.

Authors:  A C Gomes; I Falcão-Pires; A L Pires; C Brás-Silva; A F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

7.  Spontaneous cardiac calcinosis in BALB/cByJ mice.

Authors:  Aaron M Glass; Wanda Coombs; Steven M Taffet
Journal:  Comp Med       Date:  2013-02       Impact factor: 0.982

8.  Activation of Ca-permeable cation channels by myocarditis-associated antibody in guinea pig ventricular myocytes.

Authors:  M Tominaga; A Matsumori; M Horie; H Yoshida; Y Okada
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

Review 9.  Myocardial diseases of animals.

Authors:  J F Van Vleet; V J Ferrans
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

10.  Cetirizine a histamine H1 receptor antagonist improves viral myocarditis.

Authors:  Akira Matsumori; Kanjo Yamamoto; Miho Shimada
Journal:  J Inflamm (Lond)       Date:  2010-08-04       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.